Filed Pursuant to Rule 424(b)(7)
Registration No.: 333-278700
Prospectus Supplement No. 1 Filed Pursuant to Rule 424(b)(7)
(to Prospectus dated June 24, 2024)
SOLIDION TECHNOLOGY, INC.
Up to 41,066,656 Shares of Common Stock
(Including up to 35,933,324 Shares of Common Stock Issuable Upon Exercise of Warrants)
Offered by the Selling Securityholders
This prospectus supplement updates and amends the selling securityholders information contained in the prospectus, dated June 24, 2024 (as supplemented, the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-278700). The Prospectus originally registered for resale up to 41,066,656 shares of common stock, $0.001 par value per share (the “Common Stock”), which consists of (i) 5,133,332 shares of Common Stock issued pursuant to that certain Securities Purchase Agreement, dated March 13, 2024, by and between us and the selling securityholders (the “Purchase Agreement”), and (ii) 35,933,324 shares of Common Stock issuable upon the exercise of the warrants issued pursuant to the Purchase Agreement (the “Warrants”).
This prospectus supplement is being filed by the Company to update the table under the caption “Selling Securityholder” to reflect the number of shares of Common Stock issuable to the selling securityholders upon exercise of the Warrants following reset of the exercise price of the Warrants (the “Reset Shares”). The Reset Shares were included in the 41,066,656 shares of Common Stock that were registered under the Registration Statement.
This prospectus supplement should be read in conjunction with the Prospectus. This prospectus supplement is not complete without, and may not be utilized except in connection with, the Prospectus, including any amendments or supplements thereto. If there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.
See the section entitled “Risk Factors” beginning on page 6 of the Prospectus to read about factors you should consider before buying our securities.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is July 19, 2024.
SELLING SECURITYHOLDERS
The shares of our Common Stock being offered by the selling securityholders are (i) 5,133,332 shares of Common Stock issued pursuant to that certain Securities Purchase Agreement, dated March 13, 2024, by and between us and the selling securityholders (the “Purchase Agreement”), and (ii) 35,933,324 shares of Common Stock issuable upon the exercise of the warrants issued pursuant to the Purchase Agreement (the “Warrants”). For additional information regarding the issuance of the shares of Common Stock, see “Prospectus Summary — Equity Financing” above. We are registering the resale of the Common Stock and shares of our common stock issuable upon exercise of the Warrants in order to permit the selling securityholders to offer the shares of our Common Stock for resale from time to time. Except for the ownership of the Common Stock and the Warrants, the selling securityholders have not had any material relationship with us within the past three years.
Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to our common stock. Generally, a person “beneficially owns” shares of our common stock if the person has or shares with others the right to vote those shares or to dispose of them, or if the person has the right to acquire voting or disposition rights within 60 days.
Except as set forth in the footnotes below, the following table sets forth, based on written representations from the selling securityholders, certain information as of the date hereof regarding the beneficial ownership of our Common Stock by the selling securityholders and the shares of Common Stock being offered by the selling securityholders. The applicable percentage ownership of common stock is based on 86,900,398 shares of Common Stock outstanding as of July 18, 2024. Information with respect to shares of Common Stock owned beneficially after the offering assumes the sale of all of the shares of common stock held by the selling securityholders or that may be acquired upon exercise of other securities.
In accordance with the terms of the Registration Rights Agreement, this prospectus generally covers the resale of the sum of (i) the number of shares of common stock issued to the selling securityholders in the Private Placement and (ii) the maximum number of shares of common stock issuable upon exercise of the Warrants. This maximum amount is determined as if the outstanding Warrants were exercised in full as of the date immediately preceding the date this registration statement was initially filed with the SEC without regard to any limitations on the exercise of the Warrants. The selling securityholders may sell all, some or none of their shares in this offering. See “Plan of Distribution.”